Leukocyte Ratios Predict Metastasis, Recurrence, and Mortality in Breast Cancer Patients Receiving Cytotoxic Chemotherapy
Medical Sciences · 2025
DOI: 10.3390/medsci13040285 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Medical Sciences, 2025. Verfasst von Carolina Coradi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Tumor Biology, State University of West Paraná, UNIOESTE, Francisco Beltrão 85601-970, Parana, Brazil. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local, Leukocytes. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brazilian National Council for Scientific and Technological Development, Secretariat of Science, Technology, and Higher Education of the State of Paraná, Araucária Foundation.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background/Objectives: Breast cancer is a leading cause of female mortality worldwide. Immune system dynamics, reflected in hematological ratios derived from leukocytes, have been increasingly recognized for their prognostic value in cancer patients. This study aimed to evaluate the clinical significance of leukocyte-based hematological ratios in breast cancer patients undergoing cytotoxic polychemotherapy, focusing on their association with prognosis, chemoresistance, recurrence, metastasis, and mortality.
Methods
A mixed observational study was conducted with 185 breast cancer patients undergoing AC-T chemotherapy. Hematologic ratios, including neutrophil-to-lymphocyte (NLR), monocyte-to-lymphocyte (MLR), and platelet-to-lymphocyte (PLR), were calculated at multiple treatment points (D0–D168) and correlated with clinical outcomes. Statistical analyses included ANOVA and ROC curve evaluations to determine the prognostic accuracy of these markers.
Results
Significant alterations in hematological ratios were observed during chemotherapy. An increase in MLR correlated with intermediate risk for death and metastasis, while elevated PLR and platelet-to-neutrophil ratio (PNR) were strongly associated with metastasis, recurrence, and mortality. Decreases in lymphocyte-to-platelet ratio (LPR) were linked to chemoresistance and adverse outcomes. ROC curve analysis identified PLR at D84 (sensitivity: 83.33%) and PNR at D126 (specificity: 87.01%) as robust prognostic markers.
Conclusions
Leukocyte-based hematological ratios provide valuable insights into immune dynamics and prognosis in breast cancer patients undergoing chemotherapy. Their integration into routine clinical evaluations could enhance risk stratification and personalized treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Tumor Biology, State University of West Paraná, UNIOESTE, Francisco Beltrão 85601-970, Parana, Brazil.
- Health Sciences Post-Graduation Program, University of West Paraná, UNIOESTE, Francisco Beltrão 85601-970, Parana, Brazil.
- Experimental Pathology Post-Graduation Program, State University of Londrina, UEL, Londrina 86057-970, Parana, Brazil.
- Department of Biological Sciences, State University of North Paraná, UENP, Bandeirantes 86360-000, Parana, Brazil.
ORCID-Profile: Carolina Coradi, Caryna Eurich Mazur, Claudiceia Risso Pascotto, Geraldo Emílio Vicentini, Guilherme Welter Wendt, Kérley Braga Pereira Bento Casaril, Léia Carolina Lucio, Lirane Elize Defante Ferreto, Tatiane Renata Fagundes, Carolina Panis
Förderung
- Brazilian National Council for Scientific and Technological Development
- Secretariat of Science, Technology, and Higher Education of the State of Paraná
- Araucária Foundation
Zitieren
APA
Coradi, C., Kawassaki, A. C. B., Vieira, A. P., Rossi, C. E., Mazur, C. E., Pascotto, C. R., Buzanello, C. V., Benvegnú, D. M., Folador, F. A. C., Vicentini, G. E., Arruda, G., Welter Wendt, G., Casaril, K. B. P. B., Lucio, L. C., Defante Ferreto, L. E., Cavagnari, M. A. V., Fagundes, T. R., Rech, D., & Panis, C. (2025). Leukocyte Ratios Predict Metastasis, Recurrence, and Mortality in Breast Cancer Patients Receiving Cytotoxic Chemotherapy. Medical Sciences. https://doi.org/10.3390/medsci13040285
Vancouver
Coradi C, Kawassaki ACB, Vieira AP, Rossi CE, Mazur CE, Pascotto CR, et al. Leukocyte Ratios Predict Metastasis, Recurrence, and Mortality in Breast Cancer Patients Receiving Cytotoxic Chemotherapy. Medical Sciences. 2025. doi:10.3390/medsci13040285
BibTeX
@article{Coradi2025,
author = {Coradi, Carolina and Kawassaki, Aedra Carla Bufalo and Vieira, Ana Paula and Rossi, Camila Elizandra and Mazur, Caryna Eurich and Pascotto, Claudiceia Risso and Buzanello, Cleide Viviane and Benvegnú, Dalila Moter and Folador, Franciele Aní Caovilla and Vicentini, Geraldo Emílio and Arruda, Gisele and Welter Wendt, Guilherme and Casaril, Kérley Braga Pereira Bento and Lucio, Léia Carolina and Defante Ferreto, Lirane Elize and Cavagnari, Mariana Abe Vicente and Fagundes, Tatiane Renata and Rech, Daniel and Panis, Carolina},
title = {Leukocyte Ratios Predict Metastasis, Recurrence, and Mortality in Breast Cancer Patients Receiving Cytotoxic Chemotherapy},
journal = {Medical Sciences},
year = {2025},
doi = {10.3390/medsci13040285}
}
EUVIMED